Malignancies arising from these organs are frequently driven by abnormal activity of the receptors of these sex hormones: indeed, >90% of prostate cancers (PC) are driven by the androgen receptor (AR) and ~70% of breast cancers (BC) are driven by the estrogen receptor-α (ER) [1]. Here, ESR1 is linked to prostate carcinoma.